ask="N/A"
ask_size="N/A"
average_daily_volume="151417"
bid="0.410"
bid_size="1000"
book_value="0.725"
change="-0.058"
change_from_200_day_moving_average="-0.709"
change_from_50_day_moving_average="-0.399"
change_from_52_week_high="-1.399"
change_From_52_week_low="0.041"
change_in_percent="-8.801%"
close="0.601"
dividend_pay_date="11/8/2012"
dividend_per_share="0.000"
dividend_yield="0.000"
earnings_per_share="-0.810"
ebitda="-30.60M"
eps_estimate_current_year="-0.930"
eps_estimate_next_quarter="-0.230"
eps_estimate_next_year="-0.860"
ex_dividend_date="11/9/2012"
float_shares="30530000"
high="0.700"
high_52_weeks="2.000"
last_trade_date="3/6/2017"
last_trade_price="0.601"
last_trade_size="714"
last_trade_time="4:00pm"
low="0.600"
low_52_weeks="0.560"
market_capitalization="23.23M"
moving_average_200_day="1.310"
moving_average_50_day="1.000"
name="Aviragen Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.170"
open="0.670"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-54.109%"
percent_change_from_50_day_moving_average="-39.882%"
percent_change_from_52_week_high="-69.950%"
percent_change_from_52_week_low="+7.321%"
previous_close="0.659"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.909"
price_per_sales="2.599"
revenue="9.80M"
shares_outstanding="38649000"
short_ratio="0.380"
stock_exchange="NMS"
symbol="AVIR"
volume="150624"
weeks_range_52="0.560 - 2.000"
